東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/13 | 3,015 | 3,025 | 2,956 | 2,959 | -76 | -2.5% | 128,100 |
| 2025/06/12 | 3,025 | 3,060 | 3,005 | 3,035 | +15 | +0.5% | 92,600 |
| 2025/06/11 | 3,060 | 3,075 | 3,020 | 3,020 | -30 | -1% | 86,100 |
| 2025/06/10 | 3,100 | 3,115 | 3,030 | 3,050 | -50 | -1.6% | 89,300 |
| 2025/06/09 | 3,155 | 3,155 | 3,085 | 3,100 | -25 | -0.8% | 97,700 |
| 2025/06/06 | 3,200 | 3,210 | 3,120 | 3,125 | -65 | -2% | 75,500 |
| 2025/06/05 | 3,220 | 3,240 | 3,190 | 3,190 | -25 | -0.8% | 104,700 |
| 2025/06/04 | 3,245 | 3,260 | 3,200 | 3,215 | -45 | -1.4% | 191,000 |
| 2025/06/03 | 3,070 | 3,285 | 3,040 | 3,260 | +190 | +6.2% | 342,500 |
| 2025/06/02 | 3,055 | 3,105 | 3,035 | 3,070 | +15 | +0.5% | 134,700 |
| 2025/05/30 | 3,045 | 3,070 | 3,040 | 3,055 | -35 | -1.1% | 99,700 |
| 2025/05/29 | 3,115 | 3,130 | 3,065 | 3,090 | -10 | -0.3% | 111,500 |
| 2025/05/28 | 3,150 | 3,150 | 3,080 | 3,100 | +20 | +0.6% | 110,000 |
| 2025/05/27 | 3,120 | 3,125 | 3,080 | 3,080 | +10 | +0.3% | 86,900 |
| 2025/05/26 | 3,010 | 3,100 | 3,010 | 3,070 | +75 | +2.5% | 164,700 |
| 2025/05/23 | 2,930 | 3,035 | 2,918 | 2,995 | +48 | +1.6% | 153,800 |
| 2025/05/22 | 2,935 | 2,978 | 2,887 | 2,947 | -20 | -0.7% | 163,000 |
| 2025/05/21 | 2,937 | 2,999 | 2,906 | 2,967 | +130 | +4.6% | 311,700 |
| 2025/05/20 | 2,831 | 2,875 | 2,819 | 2,837 | +31 | +1.1% | 186,800 |
| 2025/05/19 | 2,808 | 2,833 | 2,786 | 2,806 | -19 | -0.7% | 217,300 |
| 2025/05/16 | 2,655 | 2,837 | 2,655 | 2,825 | +370 | +15.1% | 584,100 |
| 2025/05/15 | 2,550 | 2,579 | 2,392 | 2,455 | -145 | -5.6% | 339,100 |
| 2025/05/14 | 2,645 | 2,645 | 2,550 | 2,600 | -54 | -2% | 132,000 |
| 2025/05/13 | 2,636 | 2,657 | 2,608 | 2,654 | +41 | +1.6% | 112,100 |
| 2025/05/12 | 2,664 | 2,673 | 2,575 | 2,613 | -41 | -1.5% | 101,200 |
| 2025/05/09 | 2,637 | 2,660 | 2,615 | 2,654 | +23 | +0.9% | 70,700 |
| 2025/05/08 | 2,675 | 2,681 | 2,608 | 2,631 | +6 | +0.2% | 119,700 |
| 2025/05/07 | 2,637 | 2,644 | 2,619 | 2,625 | -12 | -0.5% | 66,800 |
| 2025/05/02 | 2,648 | 2,672 | 2,628 | 2,637 | +17 | +0.6% | 91,400 |
| 2025/05/01 | 2,645 | 2,663 | 2,618 | 2,620 | -24 | -0.9% | 50,300 |
| 2025/04/30 | 2,637 | 2,656 | 2,621 | 2,644 | +18 | +0.7% | 83,700 |
| 2025/04/28 | 2,620 | 2,659 | 2,613 | 2,626 | +8 | +0.3% | 121,100 |
| 2025/04/25 | 2,601 | 2,633 | 2,598 | 2,618 | +21 | +0.8% | 78,500 |
| 2025/04/24 | 2,594 | 2,628 | 2,588 | 2,597 | +3 | +0.1% | 58,300 |
| 2025/04/23 | 2,584 | 2,612 | 2,572 | 2,594 | +32 | +1.2% | 105,900 |
| 2025/04/22 | 2,535 | 2,562 | 2,528 | 2,562 | +38 | +1.5% | 51,600 |
| 2025/04/21 | 2,531 | 2,541 | 2,508 | 2,524 | -24 | -0.9% | 42,300 |
| 2025/04/18 | 2,514 | 2,548 | 2,509 | 2,548 | +63 | +2.5% | 64,100 |
| 2025/04/17 | 2,492 | 2,494 | 2,468 | 2,485 | -8 | -0.3% | 48,700 |
| 2025/04/16 | 2,470 | 2,493 | 2,446 | 2,493 | +22 | +0.9% | 87,100 |
| 2025/04/15 | 2,483 | 2,498 | 2,470 | 2,471 | +32 | +1.3% | 144,800 |
| 2025/04/14 | 2,430 | 2,469 | 2,422 | 2,439 | +27 | +1.1% | 76,200 |
| 2025/04/11 | 2,426 | 2,430 | 2,379 | 2,412 | -78 | -3.1% | 105,800 |
| 2025/04/10 | 2,525 | 2,525 | 2,463 | 2,490 | +123 | +5.2% | 103,200 |
| 2025/04/09 | 2,408 | 2,417 | 2,355 | 2,367 | -91 | -3.7% | 120,900 |
| 2025/04/08 | 2,436 | 2,458 | 2,404 | 2,458 | +89 | +3.8% | 179,000 |
| 2025/04/07 | 2,330 | 2,414 | 2,298 | 2,369 | -161 | -6.4% | 267,300 |
| 2025/04/04 | 2,542 | 2,573 | 2,496 | 2,530 | -57 | -2.2% | 170,300 |
| 2025/04/03 | 2,550 | 2,602 | 2,532 | 2,587 | -43 | -1.6% | 167,600 |
| 2025/04/02 | 2,701 | 2,709 | 2,630 | 2,630 | -70 | -2.6% | 99,000 |
1～
50
件表示中 / 6973件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 295,900円 | +7.9% | -3.3% | 2.70% | 8.23倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 294,500円 | +5.1% | -7.0% | 2.72% | 19.33倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム
